Table 5.
Clinical trials conducted in Japan and registered in ClinicalTrials.gov (2 June 2005 to 1 June 2010)
| Clinical trial | Trials only registered in ClinicalTrials.gov |
Trials registered in Japanese registries and ClinicalTrials.gov |
Total | |||
|---|---|---|---|---|---|---|
| UMIN | Japic | UMIN/Japicb | Subtotal | |||
| Industry-funded |
975 |
2 |
49 |
1 |
52 |
1,027 |
| (94.9%) |
(0.2%) |
(4.8%) |
(0.1%) |
(5.1%) |
(100.0%) |
|
| Others-funded |
285 |
67 |
0 |
0 |
67 |
352 |
| (81.0%) |
(19.0%) |
(0.0%) |
(0.0%) |
(19.0%) |
(100.0%) |
|
| Industry + others funded |
23 |
4 |
0 |
0 |
4 |
27 |
| (85.2%) |
(14.8%) |
(0.0%) |
(0.0%) |
(14.8%) |
(100.0%) |
|
| Unknown funding sourcea |
3 |
0 |
0 |
0 |
0 |
3 |
| (100.0%) |
(0.0%) |
(0.0%) |
(0.0%) |
(0.0%) |
(100.0%) |
|
| Total | 1,286 |
73 |
49 |
1 |
123 |
1,409 |
| (91.3%) | (5.2%) | (3.5%) | (0.1%) | (8.7%) | (100.0%) | |
Number (percentage calculated with numbers in the last column). aRecorded as 'intervention’; bregistered in UMIN-CTR and Japic-CTI. Japic-CTI, Japan Pharmaceutical Information Center Clinical Trials Information; UMIN-CTR, University Hospital Medical Information Network Clinical Trials Registry.